SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Aaron S. Kesselheim, Eric G. Campbell, Sebastian Schneeweiss, Paula Rausch, Brian M. Lappin, Esther H. Zhou, John D. Seeger, John S. Brownstein, Steven Woloshin, Lisa M. Schwartz, Timothy Toomey, Gerald J. Dal Pan, Jerry Avorn, Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications, Drug Safety, 2015, 38, 6, 565

    CrossRef

  2. 2
    Caitlin A. Knox, Christian Hampp, Mary Willy, Almut G. Winterstein, Gerald Dal Pan, Patient understanding of drug risks: an evaluation of medication guide assessments, Pharmacoepidemiology and Drug Safety, 2015, 24, 5
  3. 3
    Lewis S. Nelson, Meredith Loh, Jeanmarie Perrone, Assuring Safety of Inherently Unsafe Medications: the FDA Risk Evaluation and Mitigation Strategies, Journal of Medical Toxicology, 2014, 10, 2, 165

    CrossRef

  4. 4
    Gerald J. Dal Pan, Ongoing Challenges in Pharmacovigilance, Drug Safety, 2014, 37, 1, 1

    CrossRef